Pasithea Therapeutics (KTTA) Change in Accured Expenses (2021 - 2024)
Historic Change in Accured Expenses for Pasithea Therapeutics (KTTA) over the last 4 years, with Q4 2024 value amounting to $483373.0.
- Pasithea Therapeutics' Change in Accured Expenses fell 2921.79% to $483373.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$1.4 million, marking a year-over-year decrease of 23375.66%. This contributed to the annual value of -$1.4 million for FY2024, which is 23375.66% down from last year.
- Latest data reveals that Pasithea Therapeutics reported Change in Accured Expenses of $483373.0 as of Q4 2024, which was down 2921.79% from -$758354.0 recorded in Q3 2024.
- Over the past 5 years, Pasithea Therapeutics' Change in Accured Expenses peaked at $682903.0 during Q4 2023, and registered a low of -$1.0 million during Q2 2024.
- In the last 4 years, Pasithea Therapeutics' Change in Accured Expenses had a median value of $51899.5 in 2021 and averaged $51557.1.
- Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 143784.23% in 2023, then crashed by 157263.06% in 2024.
- Pasithea Therapeutics' Change in Accured Expenses (Quarter) stood at -$80816.0 in 2021, then surged by 446.66% to $280153.0 in 2022, then soared by 143.76% to $682903.0 in 2023, then dropped by 29.22% to $483373.0 in 2024.
- Its last three reported values are $483373.0 in Q4 2024, -$758354.0 for Q3 2024, and -$1.0 million during Q2 2024.